Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, January 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 blog post.

To investigate the efficacy and safety of repurposed antiprotozoal and antiretroviral drugs, nitazoxanide and atazanavir/ritonavi…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.